Givinostat
Commons · Question 28287 · Tabled 3 Feb 2025 · Department of Health and Social Care · Official record
Answered 10 Feb 2025
Question
Asked by Martin Wrigley
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that NHS Trusts are (a) aware of and (b) encouraged to participate in the Givinostat Early Access Programme.
Answer
Answered by Karin Smyth, 10 Feb 2025
ITF Pharma UK, the United Kingdom marketing authorisation holder for givinostat, is providing access to givinostat through a type of compassionate use scheme called an Early Access Programme (EAP). Under the EAP, givinostat is free to both patients taking...